Modern people doing business, graphs and charts being demonstrated on the screen of a touchpad

Exact Sciences Cor (NASDAQ:EXAS) shares traded on 1.43% above secure line and closed at $96.15. The stock exchanged hands 1.37 Million shares versus average trading capacity of 1.87 Million shares. It has a market cap of $11.97 Billion.

Wall Street analysts are predicting that Exact Sciences Cor (NASDAQ:EXAS) will report earnings per share of $-0.65 in their quarterly report. For the current quarter Exact Sciences Cor (NASDAQ:EXAS) has high EPS estimates of $-0.61 in contradiction of low EPS estimates of $-0.7. However a year ago for the same quarter the company has reported $-0.33 EPS. Average estimation for the current quarter has been provided by 13 analysts.

Investors as well as the sell-side will be paying close attention to how the actual numbers compare with the estimates. Earnings surprises can have a huge impact on a company’s stock price. Several studies suggest that positive earnings surprises not only lead to an immediate hike in a stock’s price, but also to a gradual increase over time. Hence, it’s not surprising that some companies are known for routinely beating earning projections. A negative earnings surprise will usually result in a decline in share price.

A large surprise factor in either direction typically can lead to a significant swing in the stock price in the hours and days after the report. Previously Exact Sciences Cor (NASDAQ:EXAS) reported $-0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $-0.49 by $0.05 with surprise factor of 10.2%.

Exact Sciences Cor (NASDAQ:EXAS) has average revenue estimates of $152.91 Million, compared to low analyst estimates of $150 Million and high estimates of $157.6 Million for the current quarter. A total number of 12 analysts provided estimations over revenues. For the current year the company’s revenue estimates are $729.13 Million compared to low analyst estimates of $717.78 Million and high estimates of $749.9 Million according to the prediction of 13 analysts.

Taking a broader look at the analyst consensus, according to 11 analysts Exact Sciences Cor (NASDAQ:EXAS)’s price will reach at $103.73 during 52 weeks. Its minimum price target estimates has been figured out at $95 while the maximum price target forecast is established at $120.

On the other hand Exact Sciences Cor (NASDAQ:EXAS) has Relative Strength Index (RSI 14) of 64.21 along with Average True Range (ATR 14) of 3.69. Where the relative strength index (RSI) is a technical momentum indicator that compares the magnitude of recent gains to recent losses in an attempt to determine excess buying & selling conditions of an asset, it is one of the most popular technical indicators, computed on the basis of the speed and direction of a stock’s price movement. The RSI value will always move between 0 and 100; the value will be 0 if the stock falls on all 14 days, and 100, if the price moves up on all the days) as suggested by J Welles Wilder. In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. The level of 50 represents neutral market momentum and corresponds with the center line in other oscillators such as MACD (Moving Average Convergence/Divergence). The average true range (ATR) is a measure of volatility introduced by Welles Wilder.

Consequently Exact Sciences Cor (NASDAQ:EXAS)’s weekly and monthly volatility is 3.84%, 4.48% respectively.